# IgM-Enriched Immunoglobulin for Neonatal Sepsis

> **NCT04041765** · PHASE3 · UNKNOWN · sponsor: **Fakultas Kedokteran Universitas Indonesia** · enrollment: 70 (estimated)

## Conditions studied

- Neonatal Sepsis, Early-Onset
- Very Low Birth Weight Infant
- Inflammation
- Infant, Newborn, Disease

## Interventions

- **DRUG:** IgM-enriched IVIG

## Key facts

- **NCT ID:** NCT04041765
- **Lead sponsor:** Fakultas Kedokteran Universitas Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09
- **Primary completion:** 2020-06
- **Final completion:** 2020-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04041765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04041765, "IgM-Enriched Immunoglobulin for Neonatal Sepsis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04041765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*